AMR 2024 Symposium: Integrated Approaches to Predict and Prevent AMR Pandemics, May 21-22

Tuesday, May 21, 2024 - 12:00am

Register here


Session 1: AMR Education and Communication

  • “Breaking Down Barriers to Sustainable Antimicrobial Use in Cats”
    • Amelia Greiner Safi and Casey Cazer
  • "Influences of scientific storytelling and visual narratives on antimicrobial resistance"
    • Meghan McGillin and Megan Keller
  • “Bridging borders, battling bacteria: The UK's AMR National Action Plan and its international efforts across research, policy, and education”
    • Garrett Dunlap

Session Keynote

"All the mutants we could not see: Deep mutagenesis of antibiotic binding-site"

Dr. Aviram Rasouly, Senior Research Scientist, New York University & Howard Hughes Medical Institute


Session 2: Detection, Discovery and Delivery

  • “integrated phenotypic and activity-based profiling of electrophilic fragments reveals new druggable targets for antibiotics development”
    • Mikail Abbasov
  • “Antimicrobial resistance in the Fire Blight pathogen Erwinia amylovora: More than 10 years of Research Discoveries, Commercial Detection, and Extension Deliverables”
    • Kerik Cox
  • “Delivering antibiotics across the eardrum by harnessing immune cells”
    • ​​​​​​​​​​​​​​Rong Yang
  • "From the soil to the clinic, towards an understanding of triclosan resistance in Stenotrophomonas species"
    • ​​​​​​​​​​​​​​Anthony Hay
  • “RNA liquid biopsy for infectious disease”
    • ​​​​​​​​​​​​​​Iwijn De Vlaminck
  • “Detection of β-lactam resistance in staphylococci: it’s enough to mec you crazy”
    • ​​​​​​​​​​​​​​Lars Westblade

Session 3: Origins and Mechanisms of Resistance and Tolerance              

  • “Heightened sensitivity to β-lactam antibiotics due to metabolic dysregulation”
    • ​​​​​​​​​​​​​​John Helmann
  • “Incorporating resilience to antimicrobial resistance in early drug discovery efforts”
    • ​​​​​​​​​​​​​​Brian VanderVen
  • “The role of lipid A-modifying phosphoethanolamine transferases in polymyxin resistance”
    • ​​​​​​​​​​​​​​Anna Schumann
  • “Understanding salmonella capsule variations: Impact on virulence and intervention strategies”
    • ​​​​​​​​​​​​​​Gi Young Lee
  • “From Commensal to pathogen: Role of enterococcal metabolic programming during surface penetration
    • ​​​​​​​​​​​​​​Diana Morales​​​​​​​

Session Keynote

“Phenotypic screening approaches for discovering mechanistically novel antibiotic leads to combat AMR”

Dr. Terry Roemer, Chair and Chief Scientific Officer, Prokaryotics, Inc.